This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jula, A. M. Articles by Karanko, H. M. Search for Related Content PubMed PubMed Citation Articles by Jula, A. M. Articles by Karanko, H. M.

Circulation, Vol 89, 1023-1031, Copyright © 1994 by American Heart Association

ARTICLES

Effects on left ventricular hypertrophy of long-term nonpharmacological treatment with sodium restriction in mild-to-moderate essential hypertension

AM Jula and HM Karanko
Social Insurance Institution, Research and Development Unit, Turku, Finland.

BACKGROUND: Cross-sectional studies on human hypertension have suggested an association between sodium intake and left ventricular hypertrophy (LVH). METHODS AND RESULTS: The effects on LVH of a nonpharmacological treatment program based mainly on sodium restriction were examined by serial echocardiography in a 12-month controlled, randomized study that included 76 previously untreated subjects with uncomplicated mild-to-moderate hypertension. The mean daily sodium excretion of 38 subjects randomized into the treatment group decreased from 195 +/- 95 to 94 +/- 73 mmol (P < .001) at 6 months and to 109 +/- 74 mmol (P < .001) at 12 months. This was accompanied by a weight decrease from 81.4 +/- 18.0 to 79.2 +/- 17.4 kg (P < .001) at 6 months and to 80.6 +/- 17.5 kg (NS) at 12 months. The net blood pressure decrease (difference in change from baseline between the treatment and control groups) was 8.9 mm Hg (P < .001) in systolic blood pressure and 6.5 mm Hg (P < .001) in diastolic blood pressure during the first 6 months and 6.7 mm Hg (P < .01) in systolic blood pressure and 3.8 mm Hg (P < .01) in diastolic blood pressure during the last 6 months. After 12 months of sodium restriction, left ventricular mass (LVM) had decreased by 5.4% (from 238 +/- 63 to 225 +/- 51 g, P < .01), and LVM index (LVMI) had decreased by 4.7% (from 123 +/- 26 to 117 +/- 22 g/m2, P < .05), whereas no changes occurred in these parameters in the control group. In treated subjects with baseline LVMI of more than the median value of 133 g/m2 in men and 107 g/m2 in women, LVM decreased by 8.6% (from 272 +/- 62 to 249 +/- 51 g, P < .01), and LVMI decreased by 7.1% (from 140 +/- 23 to 130 +/- 22 g/m2, P < .01). LVM and LVMI remained unchanged in treated subjects with LVMI values equal to or less than the median. CONCLUSIONS: Our data suggest that long-term nonpharmacological treatment with moderate sodium restriction decreases LVH.

This article has been cited by other articles:

				R. J. Glassock, R. Pecoits-Filho, and S. H. Barberato Left Ventricular Mass in Chronic Kidney Disease and ESRD Clin. J. Am. Soc. Nephrol., December 1, 2009; 4(Supplement_1): S79 - S91. [Abstract] [Full Text] [PDF]

				K. M Dickinson, J. B Keogh, and P. M Clifton Effects of a low-salt diet on flow-mediated dilatation in humans Am. J. Clinical Nutrition, February 1, 2009; 89(2): 485 - 490. [Abstract] [Full Text] [PDF]

				B. D. Dickinson, S. Havas, and for the Council on Science and Public Health, Amer Reducing the Population Burden of Cardiovascular Disease by Reducing Sodium Intake: A Report of the Council on Science and Public Health Arch Intern Med, July 23, 2007; 167(14): 1460 - 1468. [Abstract] [Full Text] [PDF]

				N. R Cook, J. A Cutler, E. Obarzanek, J. E Buring, K. M Rexrode, S. K Kumanyika, L. J Appel, and P. K Whelton Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP) BMJ, April 28, 2007; 334(7599): 885 - 885. [Abstract] [Full Text] [PDF]

				A. Aviv Salt and Hypertension: The Debate That Begs the Bigger Question Arch Intern Med, February 26, 2001; 161(4): 507 - 510. [Full Text] [PDF]

				N. M Kaplan The dietary guideline for sodium: should we shake it up? No Am. J. Clinical Nutrition, May 1, 2000; 71(5): 1020 - 1026. [Abstract] [Full Text] [PDF]

				M. J. Turner, R. J. Spina, W. M. Kohrt, and A. A. Ehsani Effect of Endurance Exercise Training on Left Ventricular Size and Remodeling in Older Adults With Hypertension J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2000; 55(4): 245M - 251. [Abstract] [Full Text]

				N. A. Graudal, A. M. Galloe, and P. Garred Effects of Sodium Restriction on Blood Pressure, Renin, Aldosterone, Catecholamines, Cholesterols, and Triglyceride: A Meta-analysis JAMA, May 6, 1998; 279(17): 1383 - 1391. [Abstract] [Full Text] [PDF]

				F. H. Messerli, R. E. Schmieder, and M. R. Weir Salt: A Perpetrator of Hypertensive Target Organ Disease? Arch Intern Med, November 24, 1997; 157(21): 2449 - 2452. [Abstract] [PDF]

				R. E. Schmieder, P. Martus, and A. Klingbeil Reversal of Left Ventricular Hypertrophy in Essential Hypertension: A Meta-analysis of Randomized Double-blind Studies JAMA, May 15, 1996; 275(19): 1507 - 1513. [Abstract] [PDF]

				M. J. Roman, T. G. Pickering, R. Pini, J. E. Schwartz, and R. B. Devereux Prevalence and Determinants of Cardiac and Vascular Hypertrophy in Hypertension Hypertension, August 1, 1995; 26(2): 369 - 373. [Abstract] [Full Text]

				P. R. Liebson, G. A. Grandits, S. Dianzumba, R. J. Prineas, R. H. Grimm Jr, J. D. Neaton, and J. Stamler Comparison of Five Antihypertensive Monotherapies and Placebo for Change in Left Ventricular Mass in Patients Receiving Nutritional-Hygienic Therapy in the Treatment of Mild Hypertension Study (TOMHS) Circulation, February 1, 1995; 91(3): 698 - 706. [Abstract] [Full Text]